AbbVie | ABBV - Interest Income


AbbVie reported $72M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
AbbVie USD 72M 13M Mar/2026
Abbott USD 106M 28M Mar/2026
ALKERMES USD 8.54M 3.59M Mar/2026
AstraZeneca USD 80M 7M Jun/2026
Biogen USD 37.9M 700K Mar/2026
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
Eisai JPY 3.11B 783M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Gilead Sciences USD 95M 0 Mar/2026
GlaxoSmithKline GBP 22M 96M Mar/2026
J&J USD 2.27 0.13 Jun/2026
Medtronic USD 114M 23M Jan/2025
Merck USD 35M 34M Mar/2026
Pacira USD 1.93M 365K Mar/2026
Pfizer USD -0.04 115M Jun/2026
Regeneron Pharmaceuticals USD 183.3M 200K Jun/2026
Sanofi EUR 77M 17M Jun/2026
Ultragenyx Pharmaceutical USD 6M 512K Mar/2026
United Therapeutics USD 41.8M 1.4M Mar/2026
Vertex Pharmaceuticals USD 114.8M 7.1M Mar/2026
Zoetis USD 25M 1000K Dec/2025